Pacira BioSciences, Inc. PCRX Other — Due 2027
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PurchaseObligationDueInSecondYear.
The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s other — due 2027.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s other — due 2027?
- Pacira BioSciences, Inc. (PCRX) reported other — due 2027 of $800K in Q4 2025.
- What does other — due 2027 mean?
- Represents the portion of contractual purchase obligations within the 'Other' business segment that are scheduled for payment during the fiscal year 2027. This metric is essential for modeling the company's multi-year cash flow requirements and assessing the impact of fixed commitments on future operating margins. It helps investors understand the maturity profile of the company's operational liabilities.